Literature DB >> 3814825

Blast cell colony assay for umbilical cord blood and adult bone marrow progenitors.

A G Leary, M Ogawa.   

Abstract

We previously described candidate human blast cell colonies in culture of umbilical cord blood cells. However, their replating efficiencies were low, and we were unable to grow colonies from adult marrow cells. We report here a consistent method of growth and identification of human blast cell colonies that are supported by low serum culture and by delayed addition of medium conditioned by a T lymphoblast cell line, C5MJ. Nonadherent mononuclear cord blood and bone marrow cells were prepared by use of Ficoll-Paque and overnight adherence to plastic. Bone marrow cells were further enriched for progenitors by panning with monoclonal anti-My-10 antibody. Cells were plated in methylcellulose culture containing 2% fetal calf serum and supplemented with bovine serum albumin, lecithin, cholesterol, and transferrin. On day 14 of culture, concentrated C5MJ-conditioned medium was carefully added to each dish. Blast cell colonies consisting of 18 to 100 cells were detected on days 21 to 28. Forty percent to 75% of the blast cell colonies in individual samples yielded secondary colonies upon replating (positive colonies). The replating efficiency of the positive colonies ranged from 3% to 100%. The largest secondary colony contained 7,800 cells. In addition to single-lineage colonies, multilineage colonies revealing two to five lineage combinations were seen. These results suggest that human primitive progenitors are dormant in cell cycle and that they survive in the absence of colony-stimulating factors. Human blast cell colonies may provide a unique population of progenitors for studies of the early process of human hemopoiesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3814825

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

Review 1.  The potential role of adult stem cells in the management of the rheumatic diseases.

Authors:  Tiziana Franceschetti; Cosimo De Bari
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-04-20       Impact factor: 5.346

Review 2.  Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine.

Authors:  Patricia Flores-Guzmán; Verónica Fernández-Sánchez; Hector Mayani
Journal:  Stem Cells Transl Med       Date:  2013-10-07       Impact factor: 6.940

Review 3.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

4.  Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro.

Authors:  J Brandt; N Baird; L Lu; E Srour; R Hoffman
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

5.  Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers.

Authors:  H J Sutherland; P M Lansdorp; D H Henkelman; A C Eaves; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Survival of hemopoietic progenitors in the G0 period of the cell cycle does not require early hemopoietic regulators.

Authors:  A G Leary; Y Hirai; T Kishimoto; S C Clark; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 7.  Characterization of hematopoietic stem and progenitor cells.

Authors:  D E Williams; L Lu; H E Broxmeyer
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

Review 8.  Regulation of colony-stimulating factor production by normal and leukemic human cells.

Authors:  T J Ernst; J D Griffin
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

9.  Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults.

Authors:  A A Cardoso; M L Li; P Batard; A Hatzfeld; E L Brown; J P Levesque; H Sookdeo; B Panterne; P Sansilvestri; S C Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

10.  Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors.

Authors:  A G Leary; H Q Zeng; S C Clark; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.